News

NCCN completes resource on radiation therapy


 

Photo by Rhoda Baer

Therapist preparing patient to receive radiation

The National Comprehensive Cancer Network® (NCCN) has announced the release of the newly completed NCCN Radiation Therapy Compendium™.

This resource includes information designed to support clinical decision-making regarding the use of radiation therapy in cancer patients.

The content is based on the NCCN Clinical Practice Guidelines in Oncology and includes information from the 41 guidelines that reference radiation therapy.

“By compiling every recommendation for radiation therapy in one place, we’ve made it significantly easier for specialists . . . to stay up-to-date on the very latest recommendations, regardless of how many different cancer types they treat,” said Robert W. Carlson, MD, chief executive officer of NCCN.

“This targeted content provides radiation oncologists with the specific, cutting-edge information they need, without forcing them to sift through any extraneous information. It’s part of our ongoing effort to always provide the most pertinent data on emerging treatment practices in the clearest, most efficient way possible.”

The NCCN Radiation Therapy Compendium includes a full complement of radiation therapy recommendations found in the current NCCN guidelines, including specific treatment modalities such as 2D/3D conformal external beam radiation therapy, intensity modulated radiation therapy, intra-operative radiation therapy, stereotactic radiosurgery/stereotactic body radiotherapy/stereotactic ablative body radiotherapy, image-guided radiation therapy, low dose-rate/high dose-rate brachytherapy, radioisotope, and particle therapy.

NCCN first announced the launch of the Radiation Therapy Compendium in March at the NCCN Annual Conference: Improving the Quality, Effectiveness, and Efficiency of Cancer Care.

At the time, the NCCN released a preliminary version of the compendium featuring 24 cancer types. The newly completed version now contains all 41 disease sites that are currently being treated using radiation therapy.

The compendium will be updated on a continual basis in conjunction with the library of clinical guidelines.

For more information and to access the NCCN Radiation Therapy Compendium, visit NCCN.org/RTCompendium. The compendium is available free-of-charge through March 2018.

Recommended Reading

ALL therapies grow, so do the complexities of choosing the order of treatments
MDedge Hematology and Oncology
Minimal residual disease measures not yet impactful for AML patients
MDedge Hematology and Oncology
Predicting neurotoxicity after CAR T-cell therapy
MDedge Hematology and Oncology
FDA grants drug fast track designation for rel/ref AML
MDedge Hematology and Oncology
FDA rejects pegfilgrastim biosimilar
MDedge Hematology and Oncology
AML trial placed on full clinical hold
MDedge Hematology and Oncology
FDA grants drug orphan designation for AML
MDedge Hematology and Oncology
Primary care may be inadequate for cancer survivors
MDedge Hematology and Oncology
Sperm banking may be underused by young cancer patients
MDedge Hematology and Oncology
Newer blood cancer drugs may not improve OS, QOL
MDedge Hematology and Oncology